NVDA's current valuation metrics are unsustainably stretched, pricing in multi-year hyper-growth and persistent multiple expansion. With a split-adjusted current price of ~$1060, the target of below $196 implies an 81%+ correction within 24 months. This is highly probable as the AI capex cycle matures and valuation multiples normalize. Current LTM P/S of ~33x and NTM P/E of ~75x are historic extremes. Projecting FY2026 revenue consensus around $170B, even a robust 10x P/S multiple (generous for a large-cap semiconductor firm) yields a market cap of $1.7T. Divided by 24.6B post-split shares, this indicates a price of ~$69.10, well below the $196 threshold. Sentiment: The current pervasive market euphoria, with an analyst consensus of overwhelmingly 'buy' ratings, historically serves as a contrarian indicator for such extended time horizons. A valuation compression to more rational levels (e.g., 5-10x P/S, 25-35x P/E) is inevitable as growth rates decelerate and competitive pressures from AMD's MI300X series and hyperscaler custom ASICs intensify. 90% YES — invalid if NVDA sustains 50%+ Y/Y revenue growth through FY2026 at a P/S multiple above 20x.
NVDA's current valuation metrics are unsustainably stretched, pricing in multi-year hyper-growth and persistent multiple expansion. With a split-adjusted current price of ~$1060, the target of below $196 implies an 81%+ correction within 24 months. This is highly probable as the AI capex cycle matures and valuation multiples normalize. Current LTM P/S of ~33x and NTM P/E of ~75x are historic extremes. Projecting FY2026 revenue consensus around $170B, even a robust 10x P/S multiple (generous for a large-cap semiconductor firm) yields a market cap of $1.7T. Divided by 24.6B post-split shares, this indicates a price of ~$69.10, well below the $196 threshold. Sentiment: The current pervasive market euphoria, with an analyst consensus of overwhelmingly 'buy' ratings, historically serves as a contrarian indicator for such extended time horizons. A valuation compression to more rational levels (e.g., 5-10x P/S, 25-35x P/E) is inevitable as growth rates decelerate and competitive pressures from AMD's MI300X series and hyperscaler custom ASICs intensify. 90% YES — invalid if NVDA sustains 50%+ Y/Y revenue growth through FY2026 at a P/S multiple above 20x.